C12N 2770/36163
By chemical treatment
Official title: by chemical treatment
C12N2770/36163 (By chemical treatment) appears on 16 US grants and 17 published applications in this corpus.
Search patents in C12N- Granted patents
- 16
- Published applications
- 17
- Assignees
- 14
- Inventors
- 38
- Latest grant
- 23 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 1 | 1 |
| 2015 | 1 | 2 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 3 |
| 2023 | 2 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production23 Sep 2025US 12,419,947 B2Najit Technologies, Inc.
- Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process1 Oct 2024US 12,102,676 B2Najit Technologies, Inc.
- Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production19 Dec 2023US 11,844,832 B2Najit Technologies, Inc.
- Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process25 Apr 2023US 11,633,470 B2Najit Technologies, Inc.
- Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process12 Oct 2021US 11,141,475 B2Najit Technologies, Inc.
- Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production15 Aug 2024US 2024/0269257 A1Najit Technologies, Inc.
- Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process2 Nov 2023US 2023/0346910 A1Najit Technologies, Inc.
- Inactivated vaccine for chikungunya virus3 Nov 2022US 2022/0347286 A1The Government of the United States, as represented by the Secretary of the Army
- Inactivation process for viruses22 Sep 2022US 2022/0298493 A1Valneva Austria GmbH
- Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process4 Aug 2022US 2022/0241395 A1Najit Technologies, Inc.
Most cited
By later US patents
- Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer42US 5,798,238 ABaxter International Inc. · 1998
- Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins33US 5,516,629 ACryopharm Corporation · 1996
- Method of inactivation of viral and bacterial blood contaminants26US 5,869,701 ABaxter International Inc. · 1999
- Method of inactivation of viral and bacterial blood contaminants13US 5,789,601 ABaxter International Inc. · 1998
- Vaccine for chikungunya virus infection7US 8,865,184 B2Bharat Biotech International Limited · 2014